Targeted Amikacin Delivery into Mycobacterial Granulomas

2026-09-20

Montes-Worboys and colleagues developed a dendritic-cell carrier system to direct fluorescently traceable amikacin into Mycobacterium avium granulomas in infected mice. The study provides proof of localization and supports cell-mediated delivery as a strategy for increasing antibiotic exposure at infected tissue, while stopping short of demonstrating superior therapeutic efficacy.

Amitriptyline HCl in Neuropharmacology Workflows

2026-09-19

Amitriptyline HCl provides a practical multi-receptor perturbation tool for receptor signaling, blood-brain barrier, and neuropharmacology assays. This guide combines concentration planning, fresh-solution handling, and lipidomics-inspired controls to improve mechanistic interpretation without overstating evidence from unrelated disease models.

Amikacin Sulfate: Reliable Cell Assays

2026-09-18

This scenario-driven guide shows how Amikacin Sulfate (SKU C8696) can support more interpretable viability, proliferation, and intracellular killing experiments. It connects concentration selection, host-cell compatibility, CFU endpoints, storage, and supplier evaluation to published amikacin data.

Adefovir (GS-0393): From Mechanism to Translation

2026-09-18

A translational perspective on Adefovir (GS-0393) that connects HBV DNA polymerase inhibition with OAT1-mediated renal pharmacokinetics, experimental design, and reproducible research workflows.

Amitriptyline HCl: Protocol and QC Guide

2026-09-17

Amitriptyline HCl (SKU B2231) provides a defined small-molecule reference for receptor-inhibition profiling, solution preparation, and controlled neuropharmacology research workflows. It is intended for assay development and in vitro mechanistic studies, not as evidence of clinical efficacy or a substitute for assay-specific validation.

Alosetron: 5-HT3 Receptor Antagonist Workflows

2026-09-17

Use Alosetron as a selective pharmacological probe for serotonin-driven gastrointestinal motility, visceral pain, and epithelial homeostasis assays. This workflow positions 5-HT3 blockade alongside, rather than in place of, the CDC42–YAP–EGF–mTOR mechanisms identified in intestinal stem-cell research.

BBB Permeability and Lysosomal Trapping Correction

2026-09-16

Sumatriptan Succinate in Inflammation Research

2026-09-16

Learn how to deploy Sumatriptan as a 5-HT1 receptor agonist in serotonergic, neuroinflammatory, and metabolism workflows. This practical guide connects receptor-level assays with cytokine, CGRP, NF-κB, and ischemia/reperfusion readouts while emphasizing salt-form verification, dose design, and reproducibility.

Ziprasidone Augmentation in Anxious Depression

2026-09-15

This post-hoc moderator analysis examined whether baseline anxious depression altered the effects of ziprasidone added to escitalopram in an 8-week randomized trial. Depression outcomes were similar in patients with and without anxious depression, while the apparent anxiety benefit in highly anxious participants was not clinically significant, limiting subgroup-based conclusions.

RRP Restores Lipid Metabolism in Hepatic IRI

2026-09-15

A 2024 Journal of Ethnopharmacology study identifies lipid metabolic restoration as a central mechanism by which Radix Rehmanniae Praeparata extracts reduce hepatic ischemia-reperfusion injury. Its evidence connects AMPK activation with suppression of SCAP-SREBP2 cholesterol synthesis and enhancement of LXRα-dependent cholesterol efflux, providing a useful framework for lipid metabolism research.

EZ Cap Cy5 Firefly Luciferase mRNA Workflow

2026-09-14

This dual-reporter transcript separates mRNA uptake from functional protein expression, making it useful for carrier screening, translation efficiency assays, and intracellular trafficking studies. Cy5 fluorescence provides an early delivery readout, while Firefly Luciferase supports sensitive endpoint or longitudinal bioluminescence measurements.

iPSC Cardiomyocytes for Chemical Risk Characterization

2026-09-14

Tsai and colleagues show that combining functional phenotypes with transcriptomic responses in human iPSC-derived cardiomyocytes can improve chemical hazard prioritization and mechanistic interpretation. Across 464 chemicals, the integrated workflow connected concentration-response activity with points of departure and exposure-based risk characterization without relying on electrophysiology alone.

Tetrandrine: An Evidence-to-Assay Guide

2026-09-13

Tetrandrine is a calcium-channel-modulating alkaloid best used as a carefully controlled mechanistic perturbation tool. This evidence-to-assay guide connects product handling, ion-channel experiments, and the limits of computational antiviral evidence.

Lamotrigine Research Workflows for Ion Channels

2026-09-12

Build reproducible Lamotrigine assays for neuronal sodium-channel, cardiac electrophysiology, serotonin, and CYP19 workflows. This guide emphasizes solvent control, concentration design, orthogonal readouts, and troubleshooting for translational epilepsy and safety studies.

Copper-Catalyzed Thioazafluoranthene Synthesis

2026-09-11

Chen and co-workers reported an air-compatible copper-catalyzed radical cascade that converts N-tosyl-8-ethynyl-1-naphthylamines into sulfur- and nitrogen-doped fluoranthene frameworks. The method combines broad synthetic utility with a notable fluorescence response, including a 143 nm Stokes shift for amino-linked products in dilute tetrahydrofuran.